Re: Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: Results from an analysis of a randomized phase III Trial: Editorial comment

Samir S. Taneja

    Research output: Contribution to journalComment/debatepeer-review

    Fingerprint

    Dive into the research topics of 'Re: Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: Results from an analysis of a randomized phase III Trial: Editorial comment'. Together they form a unique fingerprint.